Kirkland Advises Clearwater Analytics on $1.5 Billion Acquisition of Enfusion
Kirkland & Ellis is advising Clearwater Analytics (NYSE: CWAN), a provider of SaaS-based investment management, accounting, reporting, and analytics solutions, on a definitive merger agreement to acquire Enfusion, Inc. (NYSE: ENFN), a Saas solutions provider for the investment management and hedge fund industry. The purchase price is $11.25 per share, which is comprised of an approximately equal mix of cash and stock. Additionally, Clearwater will pay $30 million to terminate Enfusion’s tax receivable agreement. This equates to a purchase price of approximately $1.5 billion. The transaction was announced January 13, 2025 and is anticipated to close in Q2 of 2025, subject to approval by Enfusion shareholders, the receipt of required regulatory approvals, and customary closing conditions.
Read the transaction press release
The Kirkland team included corporate lawyers Constantine Skarvelis, Marshall Shaffer, Jimin He, Daniel Yip and Mario Kranjac; debt lawyers Jud Oswald and Andrew Hurley; capital markets lawyers Ross Leff and Christie Mok; tax lawyers Sara Zablotney and Joseph Tootle; and executive compensation lawyers Mike Krasnovsky and Anthony Ji.
